Precision Medicine Market Overview, Segmentation, Size, Growth And Forecast During 2022-2030
Precision Medicine Market |
Precision medicine is founded on a novel idea that holds that
two individuals with the same ailment do not necessarily respond to it
physically in the same way. However, it depends on the patient's symptoms, the
environment around them, and the impact of their genes. Additionally, the
ability of the patient to respond to that specific condition affects how well
doctors and researchers can plan the necessary treatment. System biology and
panomics are frequently used in Precision
Medicine Market to identify the underlying biological causes of a patient's
condition. The use of concentrated drugs to treat each patient's condition
comes next. Numerous benefits of precision medicine include effective care that
is tailored to the patient's needs and disease category.
The technology, sequencing technique, product,
application, and geography market segments for precision medicine. It is
separated into genomics, transcriptomics, and epigenomics based on technology.
The Precision Medicine
Market is divided into
segments based on sequencing technique, including sequencing by synthesis,
sequencing by ion semiconductor, sequencing by ligation, pyrosequencing, single
molecule real-time sequencing, chain termination sequencing, and nanopore
sequencing. The market for precision medicine is segmented by type of product
into categories for consumables, tools, and services. Based on the
applications, it is separated into groups for Applications include oncology,
CNS, immunology, respiratory care, infections, and other fields. It is divided
into diagnostic instrument firms, pharmaceutical and biotechnology companies,
clinical laboratories, and healthcare IT/big data companies based on the end
users. It is examined geographically across North America, Europe, the
Asia-Pacific region, and LAMEA.
The Precision Medicine Market Is Anticipated To Reach An
Estimated Value Of US$ 73,946.2 Million In 2022 And Grow At A CAGR Of 10.3%
From 2022 To 2030.
Throughout the anticipated period, the Precision Medicine
Market is anticipated to
expand profitably. The demand for precision medicines is anticipated to
increase as the incidence of cancer around the world rises and the ageing
population becomes more susceptible to disease. The market growth is
anticipated to be accelerated by government initiatives, grants, and private
sector investments in the R&D of precision medicines. Oncology cases are
predicted to rise over the course of the forecast period, and technological
advancements will also contribute to this expansion. Applications for precision
medicine, which are mostly focused on improving the treatment of oncological
disorders, are anticipated to have significant increase over the projection
period. The rising incidence of cancer and the growing number of cancer-related
medication candidates in clinical trials are the main causes of the Market
Growth.
Competitive Landscape
The top companies involved in the global Precision Medicine Market are Intomics, GENinCode, NanoString,
Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical
Industries Ltd., Merck & Co., Inc., QIAGEN, Quest Diagnostics Incorporated,
Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America
Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly.
For More Detail On Precision
Medicine Market Visit Https://Www.Globenewswire.Com/En/News-Release/2022/04/18/2423719/0/En/Global-Precision-Medicine-Market-To-Surpass-US-161-892-7-Million-By-2030-Says-Coherent-Market-Insights-CMI.Html
You Can Also Read Press Release Https://Www.Coherentmarketinsights.Com/Press-Release/Global-Precision-Medicine-Market-To-Surpass-Us-1061-Billion-Threshold-By-2025-78
Comments
Post a Comment